Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS)

Asian J Psychiatr. 2017 Dec:30:31-32. doi: 10.1016/j.ajp.2017.07.006. Epub 2017 Jul 8.

Authors

Soumitra Das¹, Sumesh T Purushothaman², Malathesh Bc³, Seshadri Sekhar Chatterjee⁴, Arjun Kartha⁵, Varun Rajan⁶

Affiliations

¹ Dept. of Psychiatry, NIMHANS, Bengaluru, India. Electronic address: soumitra_nimhans@yahoo.com.
² Department of Psychiatry, GMC, Thrissur, India. Electronic address: sumeshtp@gmail.com.
³ Forensic Psychiatry, NIMHANS, India. Electronic address: bc.malathesh@gmail.com.
⁴ Geriatric Psychiatry, NIMHANS, India. Electronic address: drsschatterjee@gmail.com.
⁵ Department of Psychiatry, Government TD Medical College, Alappuzha, Kerala, 688005, India. Electronic address: arjunkartha18@gmail.com.
⁶ Department of Psychiatry, Government TD Medical College, Alappuzha, Kerala, 688005, India. Electronic address: rooneyr67@gmail.com.

PMID: 28711682
DOI: 10.1016/j.ajp.2017.07.006

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adult
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / adverse effects*
Bromocriptine / therapeutic use
Diagnosis, Differential
Dibenzocycloheptenes
Dopamine Agonists / therapeutic use
Drug Overdose / complications*
Drug Overdose / therapy
Fluid Therapy
GABA Modulators / therapeutic use
Heterocyclic Compounds, 4 or More Rings / administration & dosage
Heterocyclic Compounds, 4 or More Rings / adverse effects*
Humans
Lorazepam / therapeutic use
Male
Neuroleptic Malignant Syndrome / diagnosis
Neuroleptic Malignant Syndrome / etiology*
Neuroleptic Malignant Syndrome / therapy
Valproic Acid / therapeutic use

Substances

Antipsychotic Agents
Dibenzocycloheptenes
Dopamine Agonists
GABA Modulators
Heterocyclic Compounds, 4 or More Rings
Bromocriptine
Valproic Acid
asenapine
Lorazepam